Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rabe

Showing results (471-480 of 646) with videos related to

Pageof 65
Sort By:
Pulmonary Therapy|June 23, 2026
Summary of Research: Dupilumab for Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Pooled Analysis of Two Phase 3, Randomised, Double-Blind, Placebo-Controlled TrialsSurya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.
Respiratory Medicine|October 13, 2019
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocolKlaus F Rabe, Fernando J Martinez, Gary T Ferguson, et al.
Frontiers in Medicine|November 5, 2025
Imaging of human airways by endoscope-compatible dynamic microscopic optical coherence tomographyCornelia Holzhausen, Hinnerk Schulz-Hildebrandt, Martin Ahrens, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 10, 2022
Long-term efficacy of dupilumab in asthma with or without chronic rhinosinusitis and nasal polypsPatrick Berger, Andrew Menzies-Gow, Anju T Peters, et al.
The Journal of Allergy and Clinical Immunology|June 9, 2005
Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthmaLaura Fregonese, Fiona J Swan, Annemarie van Schadewijk, et al.
Environmental Pollution (Barking, Essex : 1987)|July 5, 2022
Early-life exposure to tobacco smoke alters airway signaling pathways and later mortality in D. melanogasterKarolina-Theresa Sirocko, Hanna Angstmann, Stephanie Papenmeier, et al.
Journal of Leukocyte Biology|July 9, 2002
Human neutrophil defensins induce lung epithelial cell proliferation in vitroJamil Aarbiou, Marloes Ertmann, Sandra van Wetering, et al.
Respiratory Research|June 4, 2021
Raised sputum extracellular DNA confers lung function impairment and poor symptom control in an exacerbation-susceptible phenotype of neutrophilic asthmaMustafa Abdo, Mohib Uddin, Torsten Goldmann, et al.
The European Respiratory Journal|April 29, 2022
Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL<sup>-1</sup>Klaus F Rabe, Ian D Pavord, Mario Castro, et al.
JTO Clinical and Research Reports|July 26, 2022
<b>Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Sta</b> <b>ge NSCLC With High Programmed Death-Ligand 1 Express</b> <b>ion</b>Timothy Rajakumar, Rastislav Horos, Paul Kittner, et al.
Pageof 65

Showing results (471-480 of 646) with videos related to

Sort By:
Pageof 65
Pulmonary Therapy|June 23, 2026
Summary of Research: Dupilumab for Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Pooled Analysis of Two Phase 3, Randomised, Double-Blind, Placebo-Controlled TrialsSurya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.
Respiratory Medicine|October 13, 2019
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocolKlaus F Rabe, Fernando J Martinez, Gary T Ferguson, et al.
Frontiers in Medicine|November 5, 2025
Imaging of human airways by endoscope-compatible dynamic microscopic optical coherence tomographyCornelia Holzhausen, Hinnerk Schulz-Hildebrandt, Martin Ahrens, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 10, 2022
Long-term efficacy of dupilumab in asthma with or without chronic rhinosinusitis and nasal polypsPatrick Berger, Andrew Menzies-Gow, Anju T Peters, et al.
The Journal of Allergy and Clinical Immunology|June 9, 2005
Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthmaLaura Fregonese, Fiona J Swan, Annemarie van Schadewijk, et al.
Environmental Pollution (Barking, Essex : 1987)|July 5, 2022
Early-life exposure to tobacco smoke alters airway signaling pathways and later mortality in D. melanogasterKarolina-Theresa Sirocko, Hanna Angstmann, Stephanie Papenmeier, et al.
Journal of Leukocyte Biology|July 9, 2002
Human neutrophil defensins induce lung epithelial cell proliferation in vitroJamil Aarbiou, Marloes Ertmann, Sandra van Wetering, et al.
Respiratory Research|June 4, 2021
Raised sputum extracellular DNA confers lung function impairment and poor symptom control in an exacerbation-susceptible phenotype of neutrophilic asthmaMustafa Abdo, Mohib Uddin, Torsten Goldmann, et al.
The European Respiratory Journal|April 29, 2022
Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL<sup>-1</sup>Klaus F Rabe, Ian D Pavord, Mario Castro, et al.
JTO Clinical and Research Reports|July 26, 2022
<b>Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Sta</b> <b>ge NSCLC With High Programmed Death-Ligand 1 Express</b> <b>ion</b>Timothy Rajakumar, Rastislav Horos, Paul Kittner, et al.
Pageof 65